Panitumumab treatment of head and neck cancer after cetuximab-induced aseptic meningitis: Case report.

2011 ◽  
Vol 29 (15_suppl) ◽  
pp. e16033-e16033
Author(s):  
C. E. Riggs
Keyword(s):  
Head And Neck Cancer ◽  
Case Report ◽  
Head And Neck ◽  
Aseptic Meningitis ◽  
Neck Cancer ◽  
Meningitis Case

Resection and replacement of the carotid artery in metastatic head and neck cancer: literature review and case report

2003 ◽  
Vol 32 (6) ◽  
pp. 645-650 ◽  
Author(s):  
Zs. Németh ◽  
Gy. Dömötör ◽  
M. Tálos ◽  
J. Barabás ◽  
M. Ujpál ◽  
...  
Keyword(s):  
Head And Neck Cancer ◽  
Case Report ◽  
Carotid Artery ◽  
Literature Review ◽  
Head And Neck ◽  
Neck Cancer

Elevated carcinoembryonic antigen tumour marker caused by head and neck cancer: A case report and literature study

2015 ◽  
Vol 19 (2) ◽  
pp. 106-110
Author(s):  
S.I. Vingerhoedt ◽  
E. Hauben ◽  
R. Hermans ◽  
V.L. Vander Poorten ◽  
S. Nuyts
Keyword(s):  
Head And Neck Cancer ◽  
Case Report ◽  
Carcinoembryonic Antigen ◽  
Head And Neck ◽  
Neck Cancer ◽  
Tumour Marker ◽  
Literature Study

scholarly journals SIADH: A RARE ENTITY IN HEAD AND NECK CANCER- A CASE REPORT WITH REVIEW OF LITERATURE

2020 ◽  
pp. 1-3
Author(s):  
Rinsha Gireesh ◽  
Kaustubh Bendale ◽  
Subha Lakshmi ◽  
Shiva Bharani
Keyword(s):  
Head And Neck Cancer ◽  
Case Report ◽  
Survival Rate ◽  
Oral Cancer ◽  
Cancer Patient ◽  
Head And Neck ◽  
Neck Cancer ◽  
Rare Entity ◽  
Review Of Literature ◽  
Rare Finding

Hyponatremia secondary to malignancy is a rare finding. Syndrome of inappropriate ADH secretion in head and neck cancer patient can be a serious comorbidity leading to decline in the survival rate. However, most of the time it goes undetected at the outset. And the pathophysiology of this link is not clarified. This article highlights a case of SIADH developed in 40-yr-old man with oral cancer. Also, focusses on the importance of diagnosing it and rendering treatment at the earliest.

scholarly journals Hyperammonemic Encephalopathy Associated with 5-Flurouracil Infusion in Head and Neck Cancer: Case Report and Review of the Literature

2021 ◽  
Author(s):  
Saikat Das ◽  
Aftab Ahmad ◽  
Pallav Prasun ◽  
Vipin Kharade ◽  
Manish Gupta
Keyword(s):  
Adverse Effect ◽  
Head And Neck Cancer ◽  
Case Report ◽  
Head And Neck ◽  
Neck Cancer ◽  
Clinical Presentation ◽  
Cancer Case ◽  
Review Of The Literature ◽  
Hyperammonemic Encephalopathy ◽  
Chemotherapy Agents

AbstractHyperammonemic encephalopathy is an uncommon, potentially lethal adverse effect of 5-fluorouracil (5-FU). Being one of the most common and versatile chemotherapy agents, it is important to understand this important side effect of 5FU. There is paucity of data in this subject. Here, we report a case of 5FU-induced encephalopathy in a patient on induction chemotherapy for head and neck cancer. In this case report, the clinical presentation, diagnosis, and management of 5FU-induced encephalopathy is reported.

Sign in / Sign up

Export Citation Format

Share Document